Second, it should be noted that we only examined the deterioration effects of MRS2578 on AAA formation in vivo but did not explore the potential role of the P2Y6 receptor expressed on different vascular cells under MRS2578 treatment in vitro. The gene discussed is P2RY6; the disease is triple-A syndrome.